Article Text

Download PDFPDF
Stage III uterine prolapse in pregnancy as risk factor for puerperal uterine inversion
  1. Nicole Cumbo1,
  2. Alana Platukus2 and
  3. Pamela Schultz1
  1. 1 Department of OB/Gyn, Hackensack Meridian Jersey Shore University Medical Center, Neptune, New Jersey, USA
  2. 2 Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA
  1. Correspondence to Nicole Cumbo; nmcumbo{at}gmail.com

Summary

Uterine inversion is a potentially life-threatening complication of childbirth that can result in haemorrhage, hysterectomy and even death. There are many maternal risk factors associated with uterine inversion, but one rarely seen in the literature is uterine prolapse. We present the case of a multigravida in her 20s who presented at 32 weeks gestation in preterm labour. Her pregnancy was complicated by stage III uterine prolapse. She delivered a liveborn preterm male. During the third stage of labour, there was a second-degree uterine inversion. The patient was given terbutaline, and the uterus was manually replaced via the Johnson maneuverer under general anaesthesia without significant morbidity. Uterine prolapse during pregnancy may be a risk factor for uterine inversion at the time of delivery. The case presented demonstrates the management of uterine inversion following a pregnancy complicated by stage III uterine prolapse.

  • Postpartum Hemorrhage
  • Uterus
  • Pregnancy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: NC, AP and PS. The following authors gave final approval of the manuscript: NC, AP and PS. NC is the guarantor. Is the patient one of the authors of this manuscript? No.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.